Global Molecular Point of Care (POC) Market Research Report 2025(Status and Outlook)
Description
Report Overview
The Molecular Point of Care (POC) market refers to diagnostic testing performed near or at the site of patient care, delivering rapid and accurate molecular-level results without the need for centralized laboratory facilities. These tests leverage technologies such as polymerase chain reaction (PCR), isothermal amplification, and microfluidics to detect nucleic acids (DNA/RNA) for infectious diseases, genetic disorders, and other conditions, enabling real-time clinical decision-making. The market is driven by the increasing demand for decentralized testing, especially in infectious disease management (e.g., COVID-19, influenza, and STIs), as well as advancements in miniaturized, portable diagnostic devices. Key players include diagnostic companies, biotech firms, and healthcare providers, with growth further supported by regulatory approvals, rising healthcare expenditure, and the need for faster, more precise diagnostics in emergency and primary care settings. However, challenges such as high device costs, technical complexity, and stringent regulatory requirements may hinder widespread adoption in resource-limited regions. The competitive landscape is marked by innovation in multiplex testing, AI integration for data analysis, and partnerships between diagnostic manufacturers and healthcare systems.
The global Molecular Point of Care (POC) market size was estimated at USD 1083.04 million in 2024, exhibiting a CAGR of 8.25% during the forecast period.
This report provides a deep insight into the global Molecular Point of Care (POC) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Molecular Point of Care (POC) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Molecular Point of Care (POC) market in any manner.
Global Molecular Point of Care (POC) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott Laboratories
Aidian Oy
Akonni Biosystems
binx health
inc.
Biocartis NV
bioMérieux SA
Cepheid
Credo Bioscience
Curetis NV
DiaSorin S.p.A
GenMark Diagnostics
Greiner Bio-One GmbH
Meridian Bioscience
Inc.
Mesa Biotech
Inc.
QIAGEN NV
QuantuMDx Group
Quidel Corporation
Roche
Sekisui Diagnostics LLC
T2 Biosystems
Market Segmentation (by Type)
Respiratory
Other
Market Segmentation (by Application)
Clinical
Research
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Molecular Point of Care (POC) Market
Overview of the regional outlook of the Molecular Point of Care (POC) Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Molecular Point of Care (POC) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Molecular Point of Care (POC), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
The Molecular Point of Care (POC) market refers to diagnostic testing performed near or at the site of patient care, delivering rapid and accurate molecular-level results without the need for centralized laboratory facilities. These tests leverage technologies such as polymerase chain reaction (PCR), isothermal amplification, and microfluidics to detect nucleic acids (DNA/RNA) for infectious diseases, genetic disorders, and other conditions, enabling real-time clinical decision-making. The market is driven by the increasing demand for decentralized testing, especially in infectious disease management (e.g., COVID-19, influenza, and STIs), as well as advancements in miniaturized, portable diagnostic devices. Key players include diagnostic companies, biotech firms, and healthcare providers, with growth further supported by regulatory approvals, rising healthcare expenditure, and the need for faster, more precise diagnostics in emergency and primary care settings. However, challenges such as high device costs, technical complexity, and stringent regulatory requirements may hinder widespread adoption in resource-limited regions. The competitive landscape is marked by innovation in multiplex testing, AI integration for data analysis, and partnerships between diagnostic manufacturers and healthcare systems.
The global Molecular Point of Care (POC) market size was estimated at USD 1083.04 million in 2024, exhibiting a CAGR of 8.25% during the forecast period.
This report provides a deep insight into the global Molecular Point of Care (POC) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Molecular Point of Care (POC) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Molecular Point of Care (POC) market in any manner.
Global Molecular Point of Care (POC) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott Laboratories
Aidian Oy
Akonni Biosystems
binx health
inc.
Biocartis NV
bioMérieux SA
Cepheid
Credo Bioscience
Curetis NV
DiaSorin S.p.A
GenMark Diagnostics
Greiner Bio-One GmbH
Meridian Bioscience
Inc.
Mesa Biotech
Inc.
QIAGEN NV
QuantuMDx Group
Quidel Corporation
Roche
Sekisui Diagnostics LLC
T2 Biosystems
Market Segmentation (by Type)
Respiratory
Other
Market Segmentation (by Application)
Clinical
Research
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Molecular Point of Care (POC) Market
Overview of the regional outlook of the Molecular Point of Care (POC) Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Molecular Point of Care (POC) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Molecular Point of Care (POC), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
176 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Molecular Point of Care (POC)
- 1.2 Key Market Segments
- 1.2.1 Molecular Point of Care (POC) Segment by Type
- 1.2.2 Molecular Point of Care (POC) Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Molecular Point of Care (POC) Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Molecular Point of Care (POC) Market Size (M USD) Estimates and Forecasts (2020-2033)
- 2.1.2 Global Molecular Point of Care (POC) Sales Estimates and Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Molecular Point of Care (POC) Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Molecular Point of Care (POC) Product Life Cycle
- 3.3 Global Molecular Point of Care (POC) Sales by Manufacturers (2020-2025)
- 3.4 Global Molecular Point of Care (POC) Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Molecular Point of Care (POC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Molecular Point of Care (POC) Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Molecular Point of Care (POC) Market Competitive Situation and Trends
- 3.8.1 Molecular Point of Care (POC) Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Molecular Point of Care (POC) Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Molecular Point of Care (POC) Industry Chain Analysis
- 4.1 Molecular Point of Care (POC) Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Molecular Point of Care (POC) Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Molecular Point of Care (POC) Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Molecular Point of Care (POC) Market
- 5.7 ESG Ratings of Leading Companies
- 6 Molecular Point of Care (POC) Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Molecular Point of Care (POC) Sales Market Share by Type (2020-2025)
- 6.3 Global Molecular Point of Care (POC) Market Size Market Share by Type (2020-2025)
- 6.4 Global Molecular Point of Care (POC) Price by Type (2020-2025)
- 7 Molecular Point of Care (POC) Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Molecular Point of Care (POC) Market Sales by Application (2020-2025)
- 7.3 Global Molecular Point of Care (POC) Market Size (M USD) by Application (2020-2025)
- 7.4 Global Molecular Point of Care (POC) Sales Growth Rate by Application (2020-2025)
- 8 Molecular Point of Care (POC) Market Sales by Region
- 8.1 Global Molecular Point of Care (POC) Sales by Region
- 8.1.1 Global Molecular Point of Care (POC) Sales by Region
- 8.1.2 Global Molecular Point of Care (POC) Sales Market Share by Region
- 8.2 Global Molecular Point of Care (POC) Market Size by Region
- 8.2.1 Global Molecular Point of Care (POC) Market Size by Region
- 8.2.2 Global Molecular Point of Care (POC) Market Size Market Share by Region
- 8.3 North America
- 8.3.1 North America Molecular Point of Care (POC) Sales by Country
- 8.3.2 North America Molecular Point of Care (POC) Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Molecular Point of Care (POC) Sales by Country
- 8.4.2 Europe Molecular Point of Care (POC) Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Molecular Point of Care (POC) Sales by Region
- 8.5.2 Asia Pacific Molecular Point of Care (POC) Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Molecular Point of Care (POC) Sales by Country
- 8.6.2 South America Molecular Point of Care (POC) Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Molecular Point of Care (POC) Sales by Region
- 8.7.2 Middle East and Africa Molecular Point of Care (POC) Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Molecular Point of Care (POC) Market Production by Region
- 9.1 Global Production of Molecular Point of Care (POC) by Region(2020-2025)
- 9.2 Global Molecular Point of Care (POC) Revenue Market Share by Region (2020-2025)
- 9.3 Global Molecular Point of Care (POC) Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Molecular Point of Care (POC) Production
- 9.4.1 North America Molecular Point of Care (POC) Production Growth Rate (2020-2025)
- 9.4.2 North America Molecular Point of Care (POC) Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Molecular Point of Care (POC) Production
- 9.5.1 Europe Molecular Point of Care (POC) Production Growth Rate (2020-2025)
- 9.5.2 Europe Molecular Point of Care (POC) Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Molecular Point of Care (POC) Production (2020-2025)
- 9.6.1 Japan Molecular Point of Care (POC) Production Growth Rate (2020-2025)
- 9.6.2 Japan Molecular Point of Care (POC) Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Molecular Point of Care (POC) Production (2020-2025)
- 9.7.1 China Molecular Point of Care (POC) Production Growth Rate (2020-2025)
- 9.7.2 China Molecular Point of Care (POC) Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Abbott Laboratories
- 10.1.1 Abbott Laboratories Basic Information
- 10.1.2 Abbott Laboratories Molecular Point of Care (POC) Product Overview
- 10.1.3 Abbott Laboratories Molecular Point of Care (POC) Product Market Performance
- 10.1.4 Abbott Laboratories Business Overview
- 10.1.5 Abbott Laboratories SWOT Analysis
- 10.1.6 Abbott Laboratories Recent Developments
- 10.2 Aidian Oy
- 10.2.1 Aidian Oy Basic Information
- 10.2.2 Aidian Oy Molecular Point of Care (POC) Product Overview
- 10.2.3 Aidian Oy Molecular Point of Care (POC) Product Market Performance
- 10.2.4 Aidian Oy Business Overview
- 10.2.5 Aidian Oy SWOT Analysis
- 10.2.6 Aidian Oy Recent Developments
- 10.3 Akonni Biosystems
- 10.3.1 Akonni Biosystems Basic Information
- 10.3.2 Akonni Biosystems Molecular Point of Care (POC) Product Overview
- 10.3.3 Akonni Biosystems Molecular Point of Care (POC) Product Market Performance
- 10.3.4 Akonni Biosystems Business Overview
- 10.3.5 Akonni Biosystems SWOT Analysis
- 10.3.6 Akonni Biosystems Recent Developments
- 10.4 binx health
- 10.4.1 binx health Basic Information
- 10.4.2 binx health Molecular Point of Care (POC) Product Overview
- 10.4.3 binx health Molecular Point of Care (POC) Product Market Performance
- 10.4.4 binx health Business Overview
- 10.4.5 binx health Recent Developments
- 10.5 inc.
- 10.5.1 inc. Basic Information
- 10.5.2 inc. Molecular Point of Care (POC) Product Overview
- 10.5.3 inc. Molecular Point of Care (POC) Product Market Performance
- 10.5.4 inc. Business Overview
- 10.5.5 inc. Recent Developments
- 10.6 Biocartis NV
- 10.6.1 Biocartis NV Basic Information
- 10.6.2 Biocartis NV Molecular Point of Care (POC) Product Overview
- 10.6.3 Biocartis NV Molecular Point of Care (POC) Product Market Performance
- 10.6.4 Biocartis NV Business Overview
- 10.6.5 Biocartis NV Recent Developments
- 10.7 bioMérieux SA
- 10.7.1 bioMérieux SA Basic Information
- 10.7.2 bioMérieux SA Molecular Point of Care (POC) Product Overview
- 10.7.3 bioMérieux SA Molecular Point of Care (POC) Product Market Performance
- 10.7.4 bioMérieux SA Business Overview
- 10.7.5 bioMérieux SA Recent Developments
- 10.8 Cepheid
- 10.8.1 Cepheid Basic Information
- 10.8.2 Cepheid Molecular Point of Care (POC) Product Overview
- 10.8.3 Cepheid Molecular Point of Care (POC) Product Market Performance
- 10.8.4 Cepheid Business Overview
- 10.8.5 Cepheid Recent Developments
- 10.9 Credo Bioscience
- 10.9.1 Credo Bioscience Basic Information
- 10.9.2 Credo Bioscience Molecular Point of Care (POC) Product Overview
- 10.9.3 Credo Bioscience Molecular Point of Care (POC) Product Market Performance
- 10.9.4 Credo Bioscience Business Overview
- 10.9.5 Credo Bioscience Recent Developments
- 10.10 Curetis NV
- 10.10.1 Curetis NV Basic Information
- 10.10.2 Curetis NV Molecular Point of Care (POC) Product Overview
- 10.10.3 Curetis NV Molecular Point of Care (POC) Product Market Performance
- 10.10.4 Curetis NV Business Overview
- 10.10.5 Curetis NV Recent Developments
- 10.11 DiaSorin S.p.A
- 10.11.1 DiaSorin S.p.A Basic Information
- 10.11.2 DiaSorin S.p.A Molecular Point of Care (POC) Product Overview
- 10.11.3 DiaSorin S.p.A Molecular Point of Care (POC) Product Market Performance
- 10.11.4 DiaSorin S.p.A Business Overview
- 10.11.5 DiaSorin S.p.A Recent Developments
- 10.12 GenMark Diagnostics
- 10.12.1 GenMark Diagnostics Basic Information
- 10.12.2 GenMark Diagnostics Molecular Point of Care (POC) Product Overview
- 10.12.3 GenMark Diagnostics Molecular Point of Care (POC) Product Market Performance
- 10.12.4 GenMark Diagnostics Business Overview
- 10.12.5 GenMark Diagnostics Recent Developments
- 10.13 Greiner Bio-One GmbH
- 10.13.1 Greiner Bio-One GmbH Basic Information
- 10.13.2 Greiner Bio-One GmbH Molecular Point of Care (POC) Product Overview
- 10.13.3 Greiner Bio-One GmbH Molecular Point of Care (POC) Product Market Performance
- 10.13.4 Greiner Bio-One GmbH Business Overview
- 10.13.5 Greiner Bio-One GmbH Recent Developments
- 10.14 Meridian Bioscience
- 10.14.1 Meridian Bioscience Basic Information
- 10.14.2 Meridian Bioscience Molecular Point of Care (POC) Product Overview
- 10.14.3 Meridian Bioscience Molecular Point of Care (POC) Product Market Performance
- 10.14.4 Meridian Bioscience Business Overview
- 10.14.5 Meridian Bioscience Recent Developments
- 10.15 Inc.
- 10.15.1 Inc. Basic Information
- 10.15.2 Inc. Molecular Point of Care (POC) Product Overview
- 10.15.3 Inc. Molecular Point of Care (POC) Product Market Performance
- 10.15.4 Inc. Business Overview
- 10.15.5 Inc. Recent Developments
- 10.16 Mesa Biotech
- 10.16.1 Mesa Biotech Basic Information
- 10.16.2 Mesa Biotech Molecular Point of Care (POC) Product Overview
- 10.16.3 Mesa Biotech Molecular Point of Care (POC) Product Market Performance
- 10.16.4 Mesa Biotech Business Overview
- 10.16.5 Mesa Biotech Recent Developments
- 10.17 Inc.
- 10.17.1 Inc. Basic Information
- 10.17.2 Inc. Molecular Point of Care (POC) Product Overview
- 10.17.3 Inc. Molecular Point of Care (POC) Product Market Performance
- 10.17.4 Inc. Business Overview
- 10.17.5 Inc. Recent Developments
- 10.18 QIAGEN NV
- 10.18.1 QIAGEN NV Basic Information
- 10.18.2 QIAGEN NV Molecular Point of Care (POC) Product Overview
- 10.18.3 QIAGEN NV Molecular Point of Care (POC) Product Market Performance
- 10.18.4 QIAGEN NV Business Overview
- 10.18.5 QIAGEN NV Recent Developments
- 10.19 QuantuMDx Group
- 10.19.1 QuantuMDx Group Basic Information
- 10.19.2 QuantuMDx Group Molecular Point of Care (POC) Product Overview
- 10.19.3 QuantuMDx Group Molecular Point of Care (POC) Product Market Performance
- 10.19.4 QuantuMDx Group Business Overview
- 10.19.5 QuantuMDx Group Recent Developments
- 10.20 Quidel Corporation
- 10.20.1 Quidel Corporation Basic Information
- 10.20.2 Quidel Corporation Molecular Point of Care (POC) Product Overview
- 10.20.3 Quidel Corporation Molecular Point of Care (POC) Product Market Performance
- 10.20.4 Quidel Corporation Business Overview
- 10.20.5 Quidel Corporation Recent Developments
- 10.21 Roche
- 10.21.1 Roche Basic Information
- 10.21.2 Roche Molecular Point of Care (POC) Product Overview
- 10.21.3 Roche Molecular Point of Care (POC) Product Market Performance
- 10.21.4 Roche Business Overview
- 10.21.5 Roche Recent Developments
- 10.22 Sekisui Diagnostics LLC
- 10.22.1 Sekisui Diagnostics LLC Basic Information
- 10.22.2 Sekisui Diagnostics LLC Molecular Point of Care (POC) Product Overview
- 10.22.3 Sekisui Diagnostics LLC Molecular Point of Care (POC) Product Market Performance
- 10.22.4 Sekisui Diagnostics LLC Business Overview
- 10.22.5 Sekisui Diagnostics LLC Recent Developments
- 10.23 T2 Biosystems
- 10.23.1 T2 Biosystems Basic Information
- 10.23.2 T2 Biosystems Molecular Point of Care (POC) Product Overview
- 10.23.3 T2 Biosystems Molecular Point of Care (POC) Product Market Performance
- 10.23.4 T2 Biosystems Business Overview
- 10.23.5 T2 Biosystems Recent Developments
- 11 Molecular Point of Care (POC) Market Forecast by Region
- 11.1 Global Molecular Point of Care (POC) Market Size Forecast
- 11.2 Global Molecular Point of Care (POC) Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Molecular Point of Care (POC) Market Size Forecast by Country
- 11.2.3 Asia Pacific Molecular Point of Care (POC) Market Size Forecast by Region
- 11.2.4 South America Molecular Point of Care (POC) Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Molecular Point of Care (POC) by Country
- 12 Forecast Market by Type and by Application (2026-2033)
- 12.1 Global Molecular Point of Care (POC) Market Forecast by Type (2026-2033)
- 12.1.1 Global Forecasted Sales of Molecular Point of Care (POC) by Type (2026-2033)
- 12.1.2 Global Molecular Point of Care (POC) Market Size Forecast by Type (2026-2033)
- 12.1.3 Global Forecasted Price of Molecular Point of Care (POC) by Type (2026-2033)
- 12.2 Global Molecular Point of Care (POC) Market Forecast by Application (2026-2033)
- 12.2.1 Global Molecular Point of Care (POC) Sales (K Units) Forecast by Application
- 12.2.2 Global Molecular Point of Care (POC) Market Size (M USD) Forecast by Application (2026-2033)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
